ZA989719B - Polymorphs. - Google Patents

Polymorphs.

Info

Publication number
ZA989719B
ZA989719B ZA9809719A ZA989719A ZA989719B ZA 989719 B ZA989719 B ZA 989719B ZA 9809719 A ZA9809719 A ZA 9809719A ZA 989719 A ZA989719 A ZA 989719A ZA 989719 B ZA989719 B ZA 989719B
Authority
ZA
South Africa
Prior art keywords
polymorphs
Prior art date
Application number
ZA9809719A
Other languages
English (en)
Inventor
Ian Colin Appleby
Trevor Jack Newbury
Gary Nichols
Original Assignee
Pfizer Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10821150&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA989719(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Res & Dev filed Critical Pfizer Res & Dev
Publication of ZA989719B publication Critical patent/ZA989719B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyrrole Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ZA9809719A 1997-10-27 1998-10-26 Polymorphs. ZA989719B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9722662.5A GB9722662D0 (en) 1997-10-27 1997-10-27 Polymorphs

Publications (1)

Publication Number Publication Date
ZA989719B true ZA989719B (en) 2000-04-26

Family

ID=10821150

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9809719A ZA989719B (en) 1997-10-27 1998-10-26 Polymorphs.

Country Status (47)

Country Link
US (1) US6124363A (ko)
EP (1) EP1027329B1 (ko)
JP (1) JP3569495B2 (ko)
KR (1) KR100366167B1 (ko)
CN (1) CN1146537C (ko)
AP (1) AP906A (ko)
AR (1) AR015193A1 (ko)
AT (1) ATE232199T1 (ko)
AU (1) AU737668B2 (ko)
BG (1) BG64125B1 (ko)
BR (1) BR9813308A (ko)
CA (1) CA2307121C (ko)
CO (1) CO4970768A1 (ko)
DE (1) DE69811256T2 (ko)
DK (1) DK1027329T3 (ko)
DZ (1) DZ2632A1 (ko)
EA (1) EA002656B1 (ko)
ES (1) ES2190620T3 (ko)
GB (1) GB9722662D0 (ko)
GT (1) GT199800165A (ko)
HK (1) HK1033933A1 (ko)
HN (1) HN1998000165A (ko)
HR (1) HRP20000247B1 (ko)
HU (1) HUP0004735A3 (ko)
ID (1) ID24658A (ko)
IL (1) IL135435A0 (ko)
IS (1) IS2179B (ko)
MA (1) MA24683A1 (ko)
MY (1) MY123352A (ko)
NO (1) NO325630B1 (ko)
NZ (1) NZ503785A (ko)
OA (1) OA11350A (ko)
PA (1) PA8462001A1 (ko)
PE (1) PE122199A1 (ko)
PL (1) PL197379B1 (ko)
PT (1) PT1027329E (ko)
SA (1) SA98190834B1 (ko)
SI (1) SI1027329T1 (ko)
SK (1) SK5862000A3 (ko)
TN (1) TNSN98193A1 (ko)
TR (1) TR200001135T2 (ko)
TW (1) TW449589B (ko)
UA (1) UA67755C2 (ko)
UY (2) UY25222A1 (ko)
WO (1) WO1999021829A1 (ko)
YU (1) YU24000A (ko)
ZA (1) ZA989719B (ko)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10019067C1 (de) * 2000-04-18 2001-10-04 Lohmann Therapie Syst Lts Transdermales Therapeutisches System zur Abgabe von Dofetilid und seine Verwendung
US7326772B2 (en) * 2005-05-12 2008-02-05 Penta Biotech, Inc. Peptide for assaying hERG channel binding
CZ307826B6 (cs) 2017-12-01 2019-05-29 Farmak, A.S. Způsob přípravy N-[4-(2-{[2-(4-methansulfonamidofenoxy)ethyl](methyl)amino}ethyl)fenyl]methansulfonamidu (Dofetilidu)
US11696902B2 (en) 2018-08-14 2023-07-11 AltaThera Pharmaceuticals, LLC Method of initiating and escalating sotalol hydrochloride dosing
US11610660B1 (en) 2021-08-20 2023-03-21 AltaThera Pharmaceuticals LLC Antiarrhythmic drug dosing methods, medical devices, and systems

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EG18188A (en) * 1986-05-01 1992-09-30 Pfizer Ltd Process for preparation anti-arhythmia agents
EP0898964A1 (en) * 1997-08-19 1999-03-03 Pfizer Inc. Method for treating heart failure

Also Published As

Publication number Publication date
OA11350A (en) 2003-12-17
IS5426A (is) 2000-03-31
EA200000365A1 (ru) 2000-12-25
UA67755C2 (uk) 2004-07-15
PE122199A1 (es) 1999-12-02
IL135435A0 (en) 2001-05-20
PL197379B1 (pl) 2008-03-31
AP906A (en) 2000-11-30
PL340805A1 (en) 2001-02-26
MA24683A1 (fr) 1999-07-01
EP1027329B1 (en) 2003-02-05
ES2190620T3 (es) 2003-08-01
CN1278246A (zh) 2000-12-27
BG104373A (en) 2000-12-29
DE69811256T2 (de) 2003-09-18
HRP20000247B1 (en) 2002-08-31
US6124363A (en) 2000-09-26
MY123352A (en) 2006-05-31
HK1033933A1 (en) 2001-10-05
PT1027329E (pt) 2003-04-30
DE69811256D1 (de) 2003-03-13
NO20002191L (no) 2000-04-27
SA98190834B1 (ar) 2006-08-21
TW449589B (en) 2001-08-11
CO4970768A1 (es) 2000-11-07
BG64125B1 (bg) 2004-01-30
NO20002191D0 (no) 2000-04-27
KR100366167B1 (ko) 2003-01-09
ATE232199T1 (de) 2003-02-15
EA002656B1 (ru) 2002-08-29
HN1998000165A (es) 1999-02-09
EP1027329A1 (en) 2000-08-16
AU2151299A (en) 1999-05-17
IS2179B (is) 2006-12-15
GT199800165A (es) 2000-04-19
JP3569495B2 (ja) 2004-09-22
ID24658A (id) 2000-07-27
SI1027329T1 (en) 2003-04-30
AP9801371A0 (en) 1998-12-31
NZ503785A (en) 2004-11-26
TNSN98193A1 (fr) 2005-03-15
DZ2632A1 (fr) 2003-03-08
NO325630B1 (no) 2008-06-30
CA2307121C (en) 2006-12-05
SK5862000A3 (en) 2001-10-08
CN1146537C (zh) 2004-04-21
PA8462001A1 (es) 2000-05-24
KR20010031439A (ko) 2001-04-16
YU24000A (sh) 2003-02-28
BR9813308A (pt) 2000-08-22
GB9722662D0 (en) 1997-12-24
DK1027329T3 (da) 2003-02-24
HUP0004735A2 (hu) 2001-10-28
HUP0004735A3 (en) 2001-12-28
UY25222A1 (es) 2000-12-29
UY25341A1 (es) 1999-09-27
AR015193A1 (es) 2001-04-18
JP2001521023A (ja) 2001-11-06
CA2307121A1 (en) 1999-05-06
HRP20000247A2 (en) 2000-10-31
AU737668B2 (en) 2001-08-30
WO1999021829A1 (en) 1999-05-06
TR200001135T2 (tr) 2000-09-21

Similar Documents

Publication Publication Date Title
ZA989767B (en) Novel compounds.
ZA9711092B (en) Novel compounds.
HK1017317A1 (en) Printer.
ZA9710429B (en) Broad-spectrumδ-endotoxins.
HK1016976A1 (en) Resorcinyl-triazine.
ZA981926B (en) Detergent--package combination.
ZA9711567B (en) Compounds.
DE59804842D1 (en) Aliphatische, emissionsarme, sinterfähige thermoplastische polyurethanformmassen
ZA987055B (en) Substituted 4-benzoylpyrazoles.
ZA987058B (en) Substituted 4-benzoylpyrazoles.
ZA975861B (en) Bromotiacumicin compounds.
ZA9811758B (en) Novel compounds.
ZA9811503B (en) Novel compounds.
ZA982436B (en) Thiazolimine derivatives.
HK1017834A1 (en) Bodyshaper.
ZA983705B (en) Pregnan-3-ol-20-ones.
ZA989719B (en) Polymorphs.
ZA98868B (en) Novel compounds.
ZA987B (en) Substituted 4-benzoylpyrazoles.
ZA988206B (en) Piperidinylmethyloxazolidinone derivative.
ZA971466B (en) Endothelin-receptor-antagonists.
ZA979404B (en) Aspirinate compounds.
ZA981309B (en) 4-aminoalkoxy-1H-benzoimidazoles.
ZA983795B (en) Substituted 4-benzoyl-pyrazoles.
ZA981307B (en) 4-aminoethoxyindazole derivatives.